Related Experiment Videos
Endophthalmitis caused by Acinetobacter calcoaceticus. A profile
Lingam Gopal1, Anand A Ramaswamy, Hajib N Madhavan
1Vitreo Retinal Services, Sankara Nethralaya, Chennai, India. drlg@sankaranethralaya.org
Indian Journal of Ophthalmology
|January 31, 2004
Summary
This study details Acinetobacter calcoaceticus endophthalmitis cases. Ciprofloxacin showed high sensitivity, making it the preferred antibiotic for treating this eye infection.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Microbiology
Background:
- Endophthalmitis is a severe intraocular inflammation.
- Acinetobacter calcoaceticus is an opportunistic pathogen.
- Understanding its clinical profile is crucial for effective management.
Purpose of the Study:
- To describe the clinical and microbiological characteristics of endophthalmitis caused by Acinetobacter calcoaceticus.
- To evaluate treatment outcomes and identify optimal therapeutic strategies.
Main Methods:
- Retrospective case series analysis of 20 patients with Acinetobacter calcoaceticus endophthalmitis.
- Evaluation of etiological factors (postoperative, posttraumatic, endogenous, bleb-related).
- Assessment of microbiological sample positivity (aqueous and vitreous), ocular sterilization, anatomical results, and visual acuity recovery.
Main Results:
- Acinetobacter calcoaceticus endophthalmitis presented in various forms, including postoperative, posttraumatic, endogenous, and bleb-related.
- Endogenous cases showed chronicity and lacked obvious predisposing factors.
- Ocular sterilization was achieved in most cases; visual recovery was modest.
- Vitreous samples had higher smear and culture positivity than aqueous samples.
- High sensitivity to ciprofloxacin (88.9%) was observed.
Conclusions:
- Visual outcomes in Acinetobacter calcoaceticus endophthalmitis are generally modest.
- Ciprofloxacin is identified as the antibiotic of choice due to high sensitivity rates.
- Prompt diagnosis and targeted antibiotic therapy are essential for managing this condition.